Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1999
12/02/1999WO1999061419A1 Prostaglandin derivative
12/02/1999WO1999061418A2 1α-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
12/02/1999WO1999061417A2 Method for making hydroxy-25-ene-vitamin d compounds
12/02/1999WO1999061410A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
12/02/1999WO1999061409A1 Bioreductive cytotoxic agents
12/02/1999WO1999061406A2 Antiangiogenic drug to treat cancer, arthritis and retinopathy
12/02/1999WO1999061399A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene
12/02/1999WO1999061398A2 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999WO1999061085A2 Method and compositions for treatment of cancers
12/02/1999WO1999061066A2 Convection-enhanced delivery of aav vectors
12/02/1999WO1999061059A1 Minoxidil compositions for external use
12/02/1999WO1999061056A2 Methods and products for inducing mucosal immunity
12/02/1999WO1999061040A2 USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE
12/02/1999WO1999061036A1 Use of arabinoxylans for preparing a composition
12/02/1999WO1999061032A1 Process for producing composite preparation containing nucleic acid
12/02/1999WO1999061031A1 Treatment of c. difficile toxin b associated conditions
12/02/1999WO1999061030A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZOÏC ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-λB
12/02/1999WO1999061029A1 Sleep inducing agent
12/02/1999WO1999061028A1 Isoflavonoids for treatment and prevention of migraine headaches
12/02/1999WO1999061027A1 Combination therapy for treatment of refractory depression
12/02/1999WO1999061026A1 Efavirenz compressed tablet formulation
12/02/1999WO1999061025A1 Microemulsion preconcentrates containing a piperidine substance p antagonist
12/02/1999WO1999061024A1 Peripheral benzodiazepine receptor ligands
12/02/1999WO1999061023A1 Cocaine receptor binding ligands
12/02/1999WO1999061022A1 A stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole
12/02/1999WO1999061020A1 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE
12/02/1999WO1999061019A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
12/02/1999WO1999061018A1 Use of benzofuroxan derivatives in treating angina pectoris
12/02/1999WO1999061015A1 Mtp activity-lowering compositions
12/02/1999WO1999061014A2 Compositions and methods employing r(-) fluoxetine and other active ingredients
12/02/1999WO1999061013A2 COMPOUNDS HAVING IgE AFFECTING PROPERTIES
12/02/1999WO1999061012A2 Therapeutic dinucleotide and derivatives
12/02/1999WO1999061010A2 Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound
12/02/1999WO1999061009A2 PHARMACEUTICAL PREPARATIONS FOR REGULATING THE RELEASE OF INSULIN BY INFLUENCING THE β-CELL OF THE PANCREATIC ISLETS OF LANGERHANS
12/02/1999WO1999061008A2 Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals
12/02/1999WO1999061007A1 Timed-release transdermal systems containing an active ingredient
12/02/1999WO1999061005A1 Controlled release oral dosage form
12/02/1999WO1999061004A1 Controlled release lipoic acid
12/02/1999WO1999061003A1 Drug delivery system comprising a tightly compacted solid medicament stock
12/02/1999WO1999061002A1 Enteric coated pharmaceutical composition and method of manufacturing
12/02/1999WO1999061001A1 Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
12/02/1999WO1999061000A1 Powder containing fat-soluble drug
12/02/1999WO1999060999A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
12/02/1999WO1999060998A1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
12/02/1999WO1999060997A1 Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug
12/02/1999WO1999060988A2 Combination therapy for treatment of fiv infection
12/02/1999WO1999060987A2 Control of pain with endogenous cannabinoids
12/02/1999WO1999060986A2 Apoptosis modulators that interact with the huntington's disease gene
12/02/1999WO1999060985A2 Compounds, compositions and methods for treating erectile dysfunction
12/02/1999WO1999060869A1 Sitostanol formulation with emulsifier to reduce cholesterol absorption
12/02/1999WO1999060859A1 Disinfectant composition
12/02/1999WO1999060855A1 Novel nucleosides having bicyclic sugar moiety
12/02/1999WO1999053958A3 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
12/02/1999WO1999052548A3 Conjugate vaccines for the prevention of dental caries
12/02/1999WO1999052523A3 Flutamide compositions and preparations
12/02/1999WO1999052519A3 Methods for treating neuropsychiatric disorders
12/02/1999WO1999052518A3 New treatments for nervous disorders
12/02/1999WO1999051745A3 Dna immunization against chlamydia infection
12/02/1999WO1999051565A9 Novel local anesthetic compounds and uses
12/02/1999WO1999051212A3 Device for the transdermal delivery of diclofenac
12/02/1999WO1999049871A8 Method of inhibiting membrane-type matrix metalloproteinase
12/02/1999WO1999048489A3 Melatonin for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders
12/02/1999WO1999047501A3 Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection
12/02/1999WO1999046381A9 Human fgf gene and gene expression products
12/02/1999WO1999045886A3 New contraceptive kit for monotherapy
12/02/1999WO1999036064A3 Methods of treating tardive dyskinesia and other movement disorders
12/02/1999WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use
12/02/1999DE19857766A1 Retardiertes Schmerzmittel enthaltend Tilidin Retarded painkillers containing Tilidin
12/02/1999DE19824470A1 Neue Neurokininantagonisten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New Neurokininantagonisten, processes for their preparation containing these compounds and pharmaceutical compositions
12/02/1999DE19824230A1 Neues Endometriose-assoziiertes Gen Create an endometriosis-associated gene
12/02/1999DE19824123A1 New bile acid derivatives useful for preventing formation of gall stones
12/02/1999DE19823831A1 Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen New pharmaceutical use of isoleucyl thiazolidide and its salts
12/02/1999DE19823829A1 Pharmazeutische Präparate zur Regulierung der Insulin-Freisetzung durch Beeinflussung der ß-Zelle der pankreatischen Inseln Pharmaceutical preparations for the regulation of insulin release by affecting the beta cell of the pancreatic islets
12/02/1999DE19821788C1 Transdermales Therapeutisches System (TTS) Pergolid enthaltend Transdermal therapeutic system (TTS) containing pergolide
12/02/1999CA2374198A1 Combination therapy for treatment of fiv infection
12/02/1999CA2333556A1 Isoflavonoids for treatment and prevention of migraine headaches
12/02/1999CA2333537A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999CA2333392A1 Quinazolines for treating brain tumor
12/02/1999CA2333380A1 Novel nucleosides having bicyclic sugar moiety
12/02/1999CA2333320A1 Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
12/02/1999CA2333270A1 1.alpha.-hydroxy-25-ene-vitamin d, analogs and uses thereof
12/02/1999CA2333256A1 Method for making hydroxy-25-ene-vitamin d compounds
12/02/1999CA2333157A1 Novel substituted imidazole compounds
12/02/1999CA2333040A1 Imidazopyridine thrombin inhibitors
12/02/1999CA2333023A1 Naphthosulfamylmethyl penem antibacterials
12/02/1999CA2333001A1 Benzofuroxan derivatives and their use in treating angina pectoris
12/02/1999CA2332999A1 Compounds having ige affecting properties
12/02/1999CA2332989A1 Benzimidazole derivatives as modulators of ige
12/02/1999CA2332985A1 Benzimidazole analogs as down-regulators of ige
12/02/1999CA2332950A1 Use of benzofuroxan derivatives in treating angina pectoris
12/02/1999CA2332932A1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria
12/02/1999CA2332928A1 Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity
12/02/1999CA2332881A1 Minoxidil compositions for external use
12/02/1999CA2332863A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor nf-.kappa.b
12/02/1999CA2332825A1 Peripheral benzodiazepine receptor ligands
12/02/1999CA2332806A1 Bioreductive cytotoxic agents
12/02/1999CA2332617A1 Use of arabinoxylans for preparing a composition
12/02/1999CA2332540A1 Therapeutic dinucleotide and derivatives
12/02/1999CA2332511A1 Mtp activity-lowering compositions
12/02/1999CA2332459A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
1 ... 6401 6402 6403 6404 6405 6406 6407 6408 6409 6410 6411 6412 6413 6414 6415 6416 6417 6418 6419 6420 6421 ... 7860